Insider Trades48 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Buy | ELV | Gail Boudreaux | President and CEO | 2,725 | $367.79 | $90.8B | -4.02% | +52.35% | $1.0M | +0.80% | — | Trim |
| Jun 12, 2026 | Sell | ELV | Ronald W Penczek | CAO & Controller | 369 | $403.16 | $90.8B | -4.02% | +52.35% | $148.8K | -8.98% | — | Trim |
| May 19, 2026 | Sell | ELV | Ronald W Penczek | CAO & Controller | 3,062 | $348.72 | $90.8B | -4.02% | +52.35% | $1.1M | +0.00% | — | Trim |
| Mar 6, 2026 | Sell | ELV | Charles Morgan Jr Kendrick | EVP & President, Commercial | 3,196 | $284.92 | $90.8B | -4.02% | +52.35% | $910.6K | -21.33% | — | Trim |
| Mar 3, 2026 | Sell | ELV | Erin M Wessling | EVP & Chief Legal Officer | 417 | $284.03 | $90.8B | -4.02% | +52.35% | $118.4K | -2.11% | — | Trim |
| Mar 2, 2026 | Sell | ELV | Ronald W Penczek | CAO & Controller | 168 | $291.86 | $90.8B | -4.02% | +52.35% | $49.0K | -2.19% | — | Trim |
| Mar 2, 2026 | Sell | ELV | Ryan R Craig | EVP & Chief HR Officer | 334 | $284.78 | $90.8B | -4.02% | +52.35% | $95.1K | -1.47% | — | Trim |
| Mar 2, 2026 | Sell | ELV | Ratnakar Lavu | EVP & Chief Digital Info Ofr | 537 | $289.92 | $90.8B | -4.02% | +52.35% | $155.7K | -1.30% | — | Trim |
| Mar 2, 2026 | Sell | ELV | Mark Kaye | EVP & CFO | 624 | $288.39 | $90.8B | -4.02% | +52.35% | $180.0K | -0.85% | — | Trim |
| Mar 2, 2026 | Sell | ELV | Peter D Haytaian | EVP & Pres Carelon & CarelonRx | 1,647 | $291.35 | $90.8B | -4.02% | +52.35% | $479.9K | -3.07% | — | Trim |
| Mar 2, 2026 | Sell | ELV | Charles Morgan Jr Kendrick | EVP & President, Commercial | 1,678 | $291.28 | $90.8B | -4.02% | +52.35% | $488.8K | -4.05% | — | Trim |
| Mar 2, 2026 | Sell | ELV | Felicia F Norwood | EVP &Chief Health Benefits Ofr | 1,917 | $291.47 | $90.8B | -4.02% | +52.35% | $558.8K | -2.02% | — | Trim |
| Mar 2, 2026 | Sell | ELV | Gail Boudreaux | President and CEO | 8,449 | $292.01 | $90.8B | -4.02% | +52.35% | $2.5M | -2.19% | — | Trim |
| Feb 2, 2026 | Sell | ELV | Ryan R Craig | EVP & Chief HR Officer | 279 | $341.83 | $90.8B | -4.02% | +52.35% | $95.4K | -6.47% | — | Trim |
| Oct 2, 2025 | Sell | ELV | Mark Kaye | EVP & CFO | 2,895 | $340.24 | $90.8B | -4.02% | +52.35% | $985.0K | -15.26% | — | Trim |
| Sep 3, 2025 | Sell | ELV | Erin M Wessling | EVP & Chief Legal Officer | 152 | $321.59 | $90.8B | -4.02% | +52.35% | $48.9K | -2.94% | — | Trim |
| Jul 18, 2025 | Buy | ELV | Gail Boudreaux | President and CEO | 8,500 | $286.94 | $90.8B | -4.02% | +52.35% | $2.4M | +1.94% | — | Trim |
| Apr 24, 2025 | Sell | ELV | Mark Kaye | EVP & CFO | 4,588 | $424.82 | $90.8B | -4.02% | +52.35% | $1.9M | -19.47% | — | Trim |
| Mar 10, 2025 | Sell | ELV | Ronald W Penczek | CAO & Controller | 443 | $415.13 | $90.8B | -4.02% | +52.35% | $183.9K | -19.34% | — | Trim |
| Mar 3, 2025 | Sell | ELV | Ronald W Penczek | CAO & Controller | 198 | $395.50 | $90.8B | -4.02% | +52.35% | $78.3K | -6.92% | — | Trim |
| Mar 3, 2025 | Sell | ELV | Mark Kaye | EVP & CFO | 270 | $395.50 | $90.8B | -4.02% | +52.35% | $106.8K | -0.80% | — | Trim |
| Mar 3, 2025 | Sell | ELV | Ratnakar Lavu | EVP, Chief Digital & Info Off | 312 | $395.50 | $90.8B | -4.02% | +52.35% | $123.4K | -2.68% | — | Trim |
| Mar 3, 2025 | Sell | ELV | Peter D Haytaian | EVP & Pres Carelon & CarelonRx | 2,281 | $395.50 | $90.8B | -4.02% | +52.35% | $902.1K | -7.00% | — | Trim |
| Mar 3, 2025 | Sell | ELV | Felicia F Norwood | EVP & President,Gov Health Ben | 2,613 | $395.50 | $90.8B | -4.02% | +52.35% | $1.0M | -6.73% | — | Trim |
| Mar 3, 2025 | Sell | ELV | Charles Morgan Jr Kendrick | EVP & President, Commercial | 5,725 | $395.99 | $90.8B | -4.02% | +52.35% | $2.3M | -16.96% | — | Trim |
| Mar 3, 2025 | Sell | ELV | Gail Boudreaux | President and CEO | 10,396 | $395.50 | $90.8B | -4.02% | +52.35% | $4.1M | -6.22% | — | Trim |
| Nov 1, 2024 | Sell | ELV | Charles Morgan Jr Kendrick | EVP & President, Commercial | 846 | $414.01 | $90.8B | -4.02% | +52.35% | $350.3K | -10.04% | — | Trim |
| Nov 1, 2024 | Sell | ELV | Peter D Haytaian | EVP & Pres Carelon & CarelonRx | 1,649 | $414.01 | $90.8B | -4.02% | +52.35% | $682.7K | -8.73% | — | Trim |
| Oct 18, 2024 | Sell | ELV | Charles Morgan Jr Kendrick | EVP & President, Commercial | 7,417 | $432.14 | $90.8B | -4.02% | +52.35% | $3.2M | -46.82% | — | Trim |
| Oct 2, 2024 | Sell | ELV | Mark Kaye | EVP & CFO | 2,818 | $505.16 | $90.8B | -4.02% | +52.35% | $1.4M | -12.24% | — | Trim |
| Jul 22, 2024 | Sell | ELV | Gail Boudreaux | President and CEO | 34,000 | $500.98 | $90.8B | -4.02% | +52.35% | $17.0M | -4.00% | 10b5-1 | Trim |
| Apr 23, 2024 | Sell | ELV | Felicia F Norwood | EVP & President,Gov Health Ben | 27,826 | $453.64 | $90.8B | -4.02% | +52.35% | $12.6M | -5.95% | — | Trim |
| Mar 8, 2024 | Sell | ELV | Charles Morgan Jr Kendrick | EVP & President, Commercial | 2,432 | $500.46 | $90.8B | -4.02% | +52.35% | $1.2M | -13.31% | — | Trim |
| Mar 6, 2024 | Sell | ELV | Ronald W Penczek | CAO & Controller | 916 | $504.58 | $90.8B | -4.02% | +52.35% | $462.2K | -34.18% | — | Trim |
| Mar 1, 2024 | Sell | ELV | Ronald W Penczek | CAO & Controller | 383 | $499.11 | $90.8B | -4.02% | +52.35% | $191.2K | -14.41% | — | Trim |
| Mar 1, 2024 | Sell | ELV | Charles Morgan Jr Kendrick | EVP & President, Commercial | 1,484 | $499.11 | $90.8B | -4.02% | +52.35% | $740.7K | -6.30% | — | Trim |
| Mar 1, 2024 | Sell | ELV | Blair Williams Todt | EVP, CLO & CAO | 3,650 | $499.11 | $90.8B | -4.02% | +52.35% | $1.8M | -17.87% | — | Trim |
| Mar 1, 2024 | Sell | ELV | Felicia F Norwood | EVP & President,Gov Health Ben | 4,902 | $499.11 | $90.8B | -4.02% | +52.35% | $2.4M | -11.47% | — | Trim |
| Mar 1, 2024 | Sell | ELV | Gail Boudreaux | President and CEO | 19,256 | $499.11 | $90.8B | -4.02% | +52.35% | $9.6M | -11.36% | — | Trim |
| Mar 1, 2024 | Sell | ELV | Peter D Haytaian | EVP & Pres Carelon & CarelonRx | 40,409 | $376.38 | $90.8B | -4.02% | +52.35% | $15.2M | -6.25% | — | Trim |
| Jan 3, 2024 | Sell | ELV | Blair Williams Todt | EVP, CLO & CAO | 397 | $480.49 | $90.8B | -4.02% | +52.35% | $190.8K | -3.17% | — | Trim |
| Dec 14, 2023 | Sell | ELV | Blair Williams Todt | EVP, CLO & CAO | 10,984 | $397.75 | $90.8B | -4.02% | +52.35% | $4.4M | +0.00% | — | Trim |
| Dec 1, 2023 | Sell | ELV | Blair Williams Todt | EVP, CLO & CAO | 116 | $483.12 | $90.8B | -4.02% | +52.35% | $56.0K | -0.92% | — | Trim |
| Dec 1, 2023 | Sell | ELV | Blair Williams Todt | EVP, CLO & CAO | 1,525 | $454.00 | $90.8B | -4.02% | +52.35% | $692.4K | -4.60% | — | Trim |
| Nov 30, 2023 | Sell | ELV | Ronald W Penczek | CAO & Controller | 1,055 | $475.17 | $90.8B | -4.02% | +52.35% | $501.3K | -37.12% | — | Trim |
| Nov 1, 2023 | Sell | ELV | Charles Morgan Jr Kendrick | EVP & President, Commercial | 79 | $446.66 | $90.8B | -4.02% | +52.35% | $35.3K | -0.52% | — | Trim |
| Nov 1, 2023 | Sell | ELV | Peter D Haytaian | EVP & Pres Carelon & CarelonRx | 154 | $446.66 | $90.8B | -4.02% | +52.35% | $68.8K | -0.86% | — | Trim |
| Oct 24, 2023 | Sell | ELV | Ronald W Penczek | CAO & Controller | 64 | $454.35 | $90.8B | -4.02% | +52.35% | $29.1K | -2.20% | — | Trim |